Researchers study the impact of teleneurology program on timeliness of access to neurological care

FHS
July 27, 2023
6:18 pm

Accessing neurologic care often presents physical, geographical and financial challenges to patients, many of whom face chronic and disabling conditions.

ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer – Pharmaceutical Technology

In an interim readout of the Phase Ib/II Destiny-BREAST07 trial, the progression-free survival (PFS) at 12 months was 77.3% with Enhertu alone. Image credit: Shutterstock/tsyhun

June 4, 2024

With TV drug ads, what you see is not necessarily what you get

Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma

September 9, 2024

From Womb to NICU: The Nutritional Challenges of Preterm Babies

Tracy Warren, CEO of Astarte Medical Feeding early in life, particularly for a newborn, is typically breast-feeding or a bottle of formula. Infants tend to

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.